COVID-19
Older adults and those affected by the delta variant of SARS-CoV-2 experienced increased CV morbidity and mortality
Cardiovascular hospitalisation: no risk-amplification after COVID-19 vaccination
Does vilobelimab reduce mortality in severe COVID-19?
Awake proning not positive in COVID-19
Favipiravir may help patients over 60 years with COVID-19 to recover
Brensocatib fails in severe COVID-19
Inhaled agent under investigation for COVID-19
Accurate voice-based COVID-19 diagnostic test in development
Novel scoring tool for post-COVID syndrome aids clinicians and researchers
COVID-19 elevates risk of neurodegenerative disorders
More headaches in adolescents during COVID-19 pandemic
AstraZeneca vaccination and risk of cerebral venous sinus thrombosis
Large impact of COVID-19 on dementia diagnosis and care
SPRINTER: SNG001 still in the running?
Nebulised aviptadil “futile” in I-SPY COVID-19 trial
Lung transplantation after COVID-19-associated ARDS
COVI-PRONE trial on its back
Mesenchymal stem cells offer no benefit in COVID-19
Alpha-1 antitrypsin for ARDS secondary to severe COVID-19
Frailty prevalent 5 months following hospitalisation for COVID-19
Paediatric long COVID lacks definitions
Longer time between COVID shots may protect young men from heart inflammation
Use of statins for primary prevention tied to lower risk of hospitalization for COVID-19
Neurological symptoms of COVID-19 can last months
COVID-19 increases the mortality rates of patients with ALD
Cognitive, EEG, and MRI features in COVID-19 survivors
Neurological manifestations of COVID-19 worsen prognosis
New evidence for biological basis of “COVID-19 brain fog”
Impact of COVID-19 public health interventions
Telemedicine during COVID-19 pandemic highly appreciated
COVID vaccination especially important for dialysis patients
‘Startling’ heart attack finding in COVID patients
AD treatment during the pandemic: dupilumab does not raise COVID-19 infection risk
Lessons from the COVID-19 pandemic for IBD management
Impact of COVID-19 on screening for colorectal cancer
ACC issues consensus document on cardiovascular consequences of COVID-19
Alzheimer’s-like changes seen in COVID-19 patients’ brains
DLQI scores underestimated during lockdowns?
TNF blockers likely beneficial for psoriatic patients with COVID-19
Patients on immunomodulators need 2 COVID-19 vaccinations before seroconversion
COVID-19 vaccines seem safe, generally well tolerated in rheumatic, musculoskeletal diseases
Blood pressure control disrupted during the pandemic
Icosapent ethyl did not reduce the risk of hospitalisation in COVID-19
Neutral effect of P2Y12 inhibitors in non-critical COVID-19 hospitalisations
COVID-19 mRNA vaccination benefits outweigh the risk for myocarditis
Vaccine booster improves immune response in patients treated with rituximab
Vaccinated rheumatic patients carry increased risk for COVID-19 breakthrough infections
B-cell depleting medication increases COVID-19 breakthrough infection outcome risk
COVID-19 mRNA vaccine safe and tolerable in adults with autoimmune disease
Lupus patients less protected by COVID-19 vaccine
Laboratory and clinical signs 24h after hospitalisation predict MIS-C in children
MS patients at risk of hampered immune response after vaccination
Immunotherapy in MS does not influence COVID-19 severity and mortality
Anti-CD20 antibodies associated with worse COVID-19 outcomes
ECTRIMS-EAN consensus on vaccination in MS patients
Apixaban tops rivaroxaban for repeat-VTE protection in real-world analysis
Study reveals spectrum of COVID-19 brain complications
Cardiopulmonary exercise test helps define the cause of unexplained dyspnea in COVID long-haulers
Connecting, challenging, and empowering youth through their smartphone
Alcohol consumption during lockdown
Post-COVID-19 depression responds well to SSRIs
Impact of COVID-19 on patients with psychotic disorders
‘Glimpse of hope’ when anti-CD20 drugs limit vaccine antibodies
Dupilumab for atopic dermatitis linked with milder COVID-19 symptoms
Adequate response to SARS-CoV-2 vaccine in cancer patients
Cancer patients more likely to die from COVID-19 when hospital admittance is required
Third global survey of the ESMO Resilience Task Force
High COVID-19 mortality in Swiss cancer patients
Damaged skin as a possible transmission route for SARS-CoV-2
Anti-TNF therapy tied to better outcomes in IBD patients with COVID-19
Higher inflammation markers in COVID-19 patients with a first negative PCR test
Persistent fatigue following COVID-19
Risk of COVID-19-related morbidity and mortality in young and middle-aged adults
Dynamics of environmental pollution during and after COVID-19 lockdown
Telemedicine beneficial for headache care during the pandemic
Comparison of headaches after SARS-CoV-2 vaccination
Grey matter cortical changes in patients with persistent headache after COVID-19
Increased risk of cerebral venous thrombosis in COVID-19
Two-dose COVID-19 vaccination may not lead to flares in RA patients
More adults embraced at-home colorectal-cancer screening during pandemic
Serologic response to COVID-19 mRNA vaccine reduced in IBD patients on anti-TNFα
Rivaroxaban improves clinical outcomes in discharged COVID-19 patients
COVID-19: Thromboembolic risk reduction with therapeutic heparin dosing
Long COVID symptoms – Is ongoing cardiac damage the culprit?
UEGW 2021 Highlights Podcast
ECNP 2021 Highlights Podcast
EADV 2021 Highlights Podcast
COVID toes and seasonal chilblains share similar immune responses
B-cell-targeted therapy linked with severe COVID-19 among patients with arthritis
Increased risk of death in cardiac wait list patients seen early in pandemic
Psoriasis registries yield important data about COVID-19
COVID-19 affects patients and care
Vaccination feasible in people with psoriatic disease
Low COVID-19 risk for patients with psoriasis on biologic treatment
Lung-cancer trial enrollment takes a hit amid COVID-19
Vaccines induce antibodies despite cancer, immunocompromise
Telemedicine: Every light has its shadow
COVID-19-related HF: from systemic infection to cardiac inflammation
Increased COVID-19 mortality in patients with cardiorenal comorbidity
Myocardial infarction outcomes were significantly affected by the pandemic
COVID-19 in AF patients with HF: no higher mortality but longer hospital stay
Severe outcomes of COVID-19 in patients with dementia
First evidence of brainstem involvement in COVID-19
Intracerebral haemorrhage only slightly increases mortality in COVID-19 patients
Cognitive/behavioural alterations persistent after COVID-19
Neural base of persistent hyposmia after COVID-19
Neurological symptoms and complications of COVID-19 affect outcomes
COVID-19 patients with B-cell malignancies may deteriorate on bamlanivimab-etesevimab therapy
Decline in hospitalizations for heart attack and stroke persisted through 2020
Physiopathology of coagulopathy in haematological malignancies and COVID-19
Haemostatic abnormalities are associated with mortality in COVID-19
Mechanisms of COVID-19 vaccine-induced thrombotic thrombocytopenia
COVID-19 vaccine-induced immune thrombotic thrombocytopenia: discovery and diagnosis
Rituximab or JAK inhibitors increase the risk of severe COVID-19
Immunomodulatory therapies for severe COVID-19: literature update
Hair shedding related to COVID-19 doesn’t last long
Vector-based vaccines likely more effective in patients on rituximab
Blistering eruptions, including bullous pemphigoid, seen after COVID vaccine
Methotrexate use tied to weakened antibody response after first Pfizer-BioNTech vaccine shot
Pfizer/BioNTech COVID-19 vaccine seems effective, safe in HCT, CART therapy patients
Dapagliflozin fails to show a significant protective effect in COVID-19
Therapeutic anticoagulation not superior to prophylactic anticoagulation in COVID-19
Atorvastatin does not reduce mortality in COVID-19
Does COPD plus COVID-19 equal higher mortality?
Association between positive airway pressure treatment adherence and COVID-19 infection rates
Antibody treatment for COVID-19: a combination is successful
Air pollution: an underestimated negative prognostic factor for COVID-19
Healthcare workers vulnerable to SARS-CoV-2 infections
Genetic risk variants responsible for COVID-19 predisposition
No increased risk of (severe) COVID-19 among IBD patients
SARS-CoV-2 may exploit injured kidney cells to cause infection, damage
Limited added value of ECG-based mortality prediction in COVID-19 patients using machine learning
The neurological impact of COVID-19
Chemosensory dysfunction often persistent after COVID-19
Pandemic results in decreased global stroke care
Stroke uncommon in critically ill COVID-19 patients
Non-invasive ventilation tied to higher mortality than CPAP in COVID-19 pneumonia
Psoriasis and hidradenitis suppurativa during COVID-19: keep calm and carry on
COVID-19 in children – cutaneous involvement is common
Psoriasis management in times of COVID-19: the knowledge is growing steadily
Cutaneous reactions after COVID-19 vaccination: an update
Patients with autoimmune disease may not be fully protected even after second COVID shot
Non-live COVID-19 vaccines likely safe, effective in MS patients, but immune response varies
mRNA COVID-19 vaccines effective in IBD patients receiving biological therapies
Do anti-CD20 DMTs cause worse COVID-19 outcomes in MS?
Transplant saves selected patients with irreversible COVID-19 lung disease
Pfizer-BioNTech COVID-19 vaccine appears safe in cancer patients on immunotherapy
COVID-19 outcomes no worse with congenital heart disease
COVID-19 impact on gastrointestinal cancer care
Treatment delay for cholangiocarcinoma adjuvant therapy does not affect OS
Outcomes with COVID-19 acute kidney injury worse than for other AKI patients
More complicated course of COVID-19 in leukaemia patients
Older age and imatinib treatment associated with COVID-19 mortality in CML
Allogeneic SARS-CoV-2-specific T cells to treat COVID-19
Fewer CV complications than expected in AHA COVID-19 Registry
Worse COVID-19 outcomes in younger obese patients
Effects of CVD in hospitalised COVID-19 patients
Meta-analyses: ACEI/ARB and COVID-19
Unfavourable outcomes for COVID-19 patients with AF and atrial flutter
COVID-19 survival poor for hematopoietic stem cell transplant recipients
COVID has led to a drop in lung cancer diagnosis, more deaths
COVID outcomes have improved over time in patients with rheumatic disease
COVID-19 in patients with rheumatic disease: most report mild disease
Poor disease control: a risk factor for severe COVID-19
No heightened outcome risk for rheumatic patients with COVID-19
Children with rheumatic disease have no greater risk of a COVID-19 infection
COVID-19 far more deadly than seasonal flu, large study confirms
Biologic psoriasis treatment and COVID-19 risk: Contradictory results
Much to be learned about COVID-19 and the skin
Anti-cytokine therapy normalizes ACE2 expression in IBD, may protect against COVID-19
COVID-19: Continuing versus suspending ACE inhibitors and ARBs
Risk factors for thromboembolism and bleeding in COVID-19: lessons from Wuhan
The Yale COVID-19 Cardiovascular Registry
COVID-19 treatments and the importance of randomised trials
COVID-19 infections: Bronchoscopy provides additional diagnostic certainty
COVID-19 vaccines: An ongoing race
COVID-19: What is the risk of reinfection?
COVID-19 App: The Dutch experience
Secondary pulmonary fibrosis: a possible long-term effect of severe COVID-19
COVID-19 survivors benefit from structured follow-up
Early pulmonary rehabilitation post-COVID-19 aids recovery
COVID-19-associated delays in aortic-valve replacement tied to worse outcomes
Treatment times of acute STEMI have increased with COVID-19 pandemic
Crosstalk between inflammation and coagulation in severe COVID-19 infections
COVID-19 associated with higher VTE rates relative to influenza
Therapeutic anticoagulation not associated with lower mortality rates in COVID-19 ICU patients
COVID-19 not associated with heightened VTE risk after discharge
